Liz Carmouche was practically on fire when I met her at the Cannabis World Congress and Business Expo (CWCBExpo) at the Javits Center in Manhattan a few weeks ago.
For those of you who don't follow mixed martial arts, she's one of the top fighters in the Ultimate Fighting Championship (UFC). She went for nearly five minutes against the legendary bantamweight Ronda Rousey in the UFC's first-ever female fight – and she won the first MMA fight ever held in the famed Madison Square Garden.
But Carmouche was not at CWCBExpo to promote her UFC career.
She was there as a promoter and proud user of products from HempMeds, a small company specializing in cannabidiol (CBD) products.
Formerly opposed to the use of any cannabis-based products, Carmouche is now a fierce advocate for CBD.
She could make a cannabis believer out of anyone. Here's what she had to say…
About the Author
Michael A. Robinson is a 35-year Silicon Valley veteran and one of the top technology financial analysts working today. He regularly delivers winning trade recommendations to the Members of his monthly tech investing newsletter, Nova-X Report, and small-cap tech service, Radical Technology Profits. In the past two years alone, his subscribers have seen over 100 double- and triple-digit gains from his recommendations.
As a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs and high-profile industry insiders. In fact, he was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon. And he was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
In addition to being a regular guest and panelist on CNBC and Fox Business Network, Michael is also a Pulitzer Prize-nominated writer and reporter. His first book, "Overdrawn: The Bailout of American Savings" warned people about the coming financial collapse - years before "bailout" became a household word.
You can follow Michael's tech insight and product updates for free with his Strategic Tech Investor newsletter.